Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts-Reference-Cited by-同舟云学术

Editorial Commentary: Comparative Efficacy of Lamivudine and Emtricitabine: Comparing the Results of Randomized Trials and Cohorts

Published:2014-10-01 Issue:1 Volume:60 Page:154-156
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Ford Nathan¹,Hill Andrew²,Vitoria Marco¹,Mills Edward J.³⁴

Affiliation:

1. Department of HIV/AIDS, World Health Organization, Geneva, Switzerland

2. Department of Pharmacology and Therapeutics, Liverpool University, United Kingdom

3. Global Evaluative Sciences, Vancouver, Canada

4. Stanford Prevention Research Center, Stanford University School of Medicine,California

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/60/1/154/26659528/ciu767.pdf

Reference13 articles.

1. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges;Vitoria;Curr Opin HIV AIDS,2013

2. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach;World Health Organization,2013

3. Comparative efficacy of lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials;Ford;PLoS One,2013

4. Untangling the web of antiretroviral price reductions;Médecins Sans Frontières,2013

5. Increased virological failure in naive HIV-1–infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort;Rokx,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiretroviral therapy resistance mutations among HIV infected people in Kazakhstan;Scientific Reports;2022-10-13

2. Presentation to HIV care and antiretroviral therapy initiation and response in clinical practice from 2003 through 2013;International Journal of STD & AIDS;2019-07-07

3. Systematic De-escalation of Successful Triple Antiretroviral Therapy to Dual Therapy with Dolutegravir plus Emtricitabine or Lamivudine in Swiss HIV-positive Persons;EClinicalMedicine;2018-12

4. Candidates for inclusion in a universal antiretroviral regimen;Current Opinion in HIV and AIDS;2017-07

5. Top-down and bottom-up modeling in system pharmacology to understand clinical efficacy: An example with NRTIs of HIV-1;European Journal of Pharmaceutical Sciences;2016-10